Lower irisin concentration in T2DM patients could be explained by a reduced PGC-1α activity in muscle tissue of T2DM individuals, which was observed long before the discovery of irisin [52]. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.